Teligent, Inc. Announces FDA Approval of Fluocinonide Topical Solution USP, 0.05%

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update
Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.